AstraZeneca PLC
XMUN:ZEGA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AstraZeneca PLC
XMUN:ZEGA
|
UK |
|
Davide Campari Milano NV
MIL:CPR
|
IT |
|
Himax Technologies Inc
NASDAQ:HIMX
|
TW |
|
Z
|
Zimmer Biomet Holdings Inc
DUS:ZIM
|
US |
|
Research Solutions Inc
F:61I
|
US |
|
H
|
Harley-Davidson Inc
DUS:HAR
|
US |
Wall St Price Targets
ZEGA Price Targets Summary
AstraZeneca PLC
According to Wall Street analysts, the average 1-year price target for ZEGA is 107.3 EUR with a low forecast of 75.23 EUR and a high forecast of 139.8 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZEGA's stock price target?
Price Target
107.3
EUR
According to Wall Street analysts, the average 1-year price target for ZEGA is 107.3 EUR with a low forecast of 75.23 EUR and a high forecast of 139.8 EUR.
What is the Revenue forecast for AstraZeneca PLC?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 6%.
What is the Gross Profit forecast for AstraZeneca PLC?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 8 years is 6%.
What is the Operating Income forecast for AstraZeneca PLC?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 13%.
What is the Pre-Tax Income forecast for AstraZeneca PLC?
Projected CAGR
25%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 25%.
What is the Net Income forecast for AstraZeneca PLC?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 13%.
